Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 455-463

  Pfeilstöcker, Michael ^a   Reisner, Regina ^a   Nösslinger, Thomas ^a   Grüner, Helga ^a   Nowotny, Hadwiga ^a   Tüchler, Heinz ^a   Schlögl, Ernst ^a   Pittermann, Elisabeth ^a   Heinz, Renate ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Cytogenetics; MDS; Prognosis; Score

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CYTOGENETICS; FEMALE; GENETIC RISK; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; CYTOGENETICS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0032846543     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01559.x     Document Type: Article

References (23)

1. Aul, C., Gattermann, N., Germing, U., Runde, V., Heyll, A. & Schneider, W. (1994) Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score. Leukemia, 8, 1906-1913.
2. Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G. & Schneider, W. (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia, 6, 52-59.
3. Bennett, J.M., Catowsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposal for the classification or the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
4. Cassano, E., Giordano, M., Riccardi, A., Coci, A. & Cazzola, M. (1990) Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system. Haematologica, 75, 141-145.
5. Germing, U., Gattermann, N., Minning, H., Heyll, A. & Aul, C. (1998) Problems in the classification of CMML: dysplastic versus proliferative type. Leukemia Research, 22, 871-878.
6. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashaki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088 (erratum, Blood, 1998, 91, 1100).
7. Haase, D., Fonatsch, C., Freund, M., Wörmann, B., Bodenstein, H., Bartels, H., Stollmann-Gibbels, B. & Lengfelder, E. (1995) Cytogenetic findings in 179 patients with myelodysplastic syndromes. Annals of Hematology, 70, 171-187.
8. Johansson, B., Mertens, F. & Mitelman, F. (1996) Primary versus secondary neoplasia-associated chromosomal abnormalities: balanced rearrangements vs genomic imbalances. Genes, Chromosomes and Cancer, 16, 155-163.
9. Kerkhofs, H., Hermans, J., Haak, H.L. & Leeksma, C.H. (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. British Journal of Haematology, 65, 73-81.
10. Maschek, H., Gutzmer, R., Choritz, H. & Georgii, A. (1994) Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients. European Journal of Haematology, 53, 280-287.
11. Michaux, J.L. & Martiat, P. (1993) Chronic myelomonocytic leukemia (CMML): a myelodysplastic or a myeloproliferative syndrome? Leukemia and Lymphoma, 9, 35-41.
12. Mitelman, F. (ed.) (1995) ISCN: an International System for Human Cytogenetic Nomenclature. Karger, Basel.
13. Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F. & Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia, 7, 1315-1323.
14. Mufti, G., Stevens, J.R., Oscier, D.G., Hamblin, T.J. & Machin, D. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology, 59, 425-433.
15. Norusis Marija, J. (1997) SPSS Inc. SPSS Profesional Statistics 7.5. Chicago.
16. Nösslinger, T., Pfeilstöcker, M., Tüchler, H., Mühlberger, H., Grüner, H., Pittermann, E. & Heinz, R. (1998) Dysplastic versus proliferative CMML: retrospective analysis from a single institution. (Abstract). British Journal of Haematology, 102, 281.
17. Parker, J. & Mufti, G.J. (1996) Ras and myelodysplasia: lessons from the last decade. Seminars in Hematology, 33, 206-224.
18. Parlier, V., van Melle, G., Beris, P., Schmidt, P.M., Tobler, A., Haller, E. & Bellomo, M.J. (1995) Prediction of 18-month survival in patients with primary myelodysplastic syndrome: a regression model and a scoring system based on the combination of chromosome findings and the Bournemouth score. Cancer Genetics and Cytogenetics, 81, 158-165.
19. Pfeilstöcker, M., Reisner, R., Nösslinger, T., Grüner, H., Nowotny, H., Schlögl, E., Tüchler, H., Pittermann, E. & Heinz, R. (1997) Prognosis in MDS with specific reference to karyotypes: experience on 296 patients from a single institution, (Abstract). Leukemia Research, 21, (Suppl. 1), 15.
20. Sanz, G.F., Sanz, M.A, Vallespi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395-408.
21. Schweizer, D. (1981) Counterstained enhanced chromosome binding. Human Genetics, 57, 1-14.
22. Verhoef, G.E.G., Pittaluga, S., DeWolf-Peeters, C. & Boogaerts, M.A. (1995) FAB classification and myelodysplastic syndromes: merits and controversies. Annals of Hematology, 71, 3-11.
23. Worsley, A., Oscier, D.G., Stevens, J., Darlow, S., Figes, A., Mufti, G.J. & Hamblin, T.J. (1988) Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. British Journal of Haematology, 68, 17-21.